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Uropathogenic Escherichia coli (UPEC), which are
the leading cause of both acute and chronic urinary
tract infections, often secrete a labile pore-forming
toxin known as a-hemolysin (HlyA). We show that
stable insertion of HlyA into epithelial cell andmacro-
phage membranes triggers degradation of the cyto-
skeletal scaffolding protein paxillin and other host
regulatory proteins, as well as components of the
proinflammatory NFkB signaling cascade. Proteol-
ysis of these factors requires host serine proteases,
and paxillin degradation specifically involves the
serine protease mesotrypsin. The induced activation
of mesotrypsin by HlyA is preceded by redistribution
of mesotrypsin precursors from the cytosol into foci
along microtubules and within nuclei. HlyA intoxica-
tion also stimulated caspase activation, which
occurred independently of effects on host serine
proteases. HlyA-induced proteolysis of host proteins
likely allows UPEC to not only modulate epithelial
cell functions, but also disable macrophages and
suppress inflammatory responses.
INTRODUCTION
The uroepithelial cells that comprise the stratified layers of the
bladder mucosa have an exceptionally slow turnover rate, but
will often exfoliate in response to infection with uropathogenic
Escherichia coli (UPEC) (Bower et al., 2005). These bacteria
are able to bind and invade host cells, where they can replicate
to high levels, forming intracellular biofilm-like communities
(Anderson et al., 2003; Mulvey et al., 2001). Alternatively, inter-
nalized UPEC can enter a more quiescent state that likely facili-
tates long-term bacterial persistence within the urinary tract
(Blango and Mulvey, 2010; Eto et al., 2006; Mulvey et al.,
2001). The exfoliation of uroepithelial cells can function to clear
adherent and intracellular bacteria, but may also promote the
dissemination of UPEC, both within and outside of the host.
Consequently, the shedding of uroepithelial cells can be viewed
as a double-edged sword, potentially benefitting both host and
pathogen. Exfoliation in response to infection or injury triggers58 Cell Host & Microbe 11, 58–69, January 19, 2012 ª2012 Elsevier Ia rapid regenerative response in the bladder mucosa and under-
lying stromal cells (Mysorekar et al., 2009; Mysorekar et al.,
2002; Shin et al., 2011).While the regeneration of bladder urothe-
lial cells has been defined over the past few years with increasing
clarity, the host and bacterial factors that modulate bladder cell
exfoliation during the course of a urinary tract infection (UTI)
remain poorly understood.
In general, host cell exfoliation entails degradation of cell-cell
and cell-matrix contacts, presumably requiring disassembly of
focal adhesions and other functionally related structures. The
manipulation of host cell exfoliation and turnover rates within
mucosal barriers likely impacts the establishment, dissemina-
tion, and persistence of diverse bacterial pathogens both within
and outside of the urinary tract. For example, the dental path-
ogen Porphyromonas gingivalis secretes proteases that degrade
focal adhesion-associated components like focal adhesion
kinase (FAK) and the cytoskeletal scaffolding protein paxillin,
stimulating the exfoliation of oral keratinocytes and thereby
creating a niche for bacterial expansion (Nakagawa et al.,
2006). In contrast, in the intestinal tract where the continuous
shedding and rapid turnover of epithelial cells is the norm, path-
ogens may benefit by hindering host cell exfoliation. Shigella
flexneri and several other enteric pathogens accomplish this by
stabilizing focal adhesions via secretion of a protein complex
(OspE) that interacts with integrin-linked kinase and conse-
quently suppresses phosphorylation of FAK and paxillin (Kim
et al., 2009). Likewise, Neisseria gonorrhoeae can attenuate
normal host cell exfoliation within the vaginal mucosa by altering
the composition of focal adhesions via engagement of specific
carcinoembryonic antigen-related cell adhesion molecule (CEA-
CAM) host receptors (Muenzner et al., 2010). Pathogens like
Haemophilus influenzae, Neisseria meningitidis, and Moraxella
catarrhalis may act similarly at other sites within the host.
In light of these and related observations, we sought to
uncover possible mechanisms by which UPEC might disrupt
focal adhesion-associated components like paxillin and thereby
prime bladder epithelial cells for exfoliation. Our results indicate
that sublytic concentrations of the UPEC-associated pore-form-
ing toxin a-hemolysin (HlyA) can trigger rapid degradation of
paxillin as well as a subset of other host proteins involved in
cell-cell and cell-matrix interactions. We show that HlyA also
induces proteolysis of key host cell signaling factors, including
those central to host inflammatory responses. HlyA-induced
proteolysis of these proteins is indirect, occurring in parallel
with caspase activation via a pathway involving an atypicalnc.
Figure 1. Paxillin Is Degraded in UPEC-Infected Bladder cells
(A) Lysates from uninfected (UI) BECs and BECs that were infected with UTI89
for the indicated time periods were probed by western blot using antibodies
specific for paxillin. Staining for b-actin levels in each sample served as a
loading control.
(B) Lysates fromBECs transfected with the plasmids pEGFP or pEGFP-paxillin
and then infected with UTI89 for 0, 2, or 4 hr were analyzed by western blot
using antibodies specific for GFP (top), paxillin (middle), or actin (bottom). See
also Figure S1.
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strate that HlyA can similarly affect macrophages, highlighting
unexpected roles for HlyA as a modulator of both phagocyte
and epithelial cell functionality and survival.
RESULTS
UPEC Triggers Proteolysis of Paxillin
Paxillin is a 68 kDa multidomain scaffold protein that can modu-
late the dynamics of cytoskeletal rearrangements and host cell
adhesion via coordinated interactions with numerous structural
and regulatory proteins (Deakin and Turner, 2008). The stability
of paxillin in human bladder epithelial cells (BECs) infected with
the reference UPEC isolate UTI89 was monitored by western
blot analysis. Infection of BECs with UTI89 resulted in decreased
levels of paxillin within about 1.5 hr, and by 4 hr the protein
became undetectable (Figure 1A). UTI89-mediated degradation
of paxillin was confirmed in BECs made to express enhanced
green fluorescent protein (eGFP) fused to the N terminus of pax-
illin. In these transfected cells, degradation of GFP-paxillin in
response to infectionwithUTI89was observed to occur in a step-
wise fashion, resulting first in the release of GFP fused toCell Ha 10 kDa N-terminal fragment of paxillin, followed by release
of intact, full-length GFP (Figure 1B). GFP itself was not
degraded in these assays. Additional work showed that lipopoly-
saccharide (LPS), the type 1 pilus-associated adhesin FimH, and
host cell invasion by UPEC or other invasive pathogens were not
sufficient to trigger paxillin proteolysis within infected BECs
(Figure S1).
To gain further insight into what factor(s) elicit paxillin degrada-
tion in our infection assays, and to determine how widespread
this phenomenon was, we utilized a panel of other distinct
bacterial isolates to infect BECs. Of 20 UPEC isolates ex-
amined, 14 (60%) triggered proteolysis of paxillin (Figure 2A).
In contrast, paxillin remained stable in BECs infected with any
of several non-UPEC isolates tested. The non-E. coli uropatho-
gens Staphylococcus saprophyticus, S. aureus, Enterococcus
faecium, and Klebsiella pneumoniae also failed to induce paxillin
degradation. With the exception of S. aureus, we noted that each
strain that promoted loss of paxillin in these assays was also
hemolytic on blood agar plates.
Degradation of Paxillin Is Initiated by HlyA
Hemolytic activity associated with UPEC isolates is generally
attributable to the pore-forming exotoxin a-hemolysin (HlyA),
a prototypical member of the RTX (repeats-in-toxin) protein
family encoded within the hlyCABD operon (Cavalieri et al.,
1984; Linhartova´ et al., 2010; Marrs et al., 2005). We found that
targeted deletion of hlyA in UTI89 rendered this strain nonhemo-
lytic and unable to stimulate paxillin degradation in BECs (Fig-
ure 2B). Complementation of the hlyA mutant with a plasmid
(pSF4000) encoding the complete hly operon restored the
wild-type phenotypes. In many UPEC isolates, including UTI89,
the hly operon is genetically linked to a locus encoding another
toxin known as cytotoxic necrotizing factor-1 (CNF1) (Marrs
et al., 2005). Both HlyA and CNF1 have the potential to influence
host cell death and tissue turnover rates within the bladder (Doye
et al., 2002;Mills et al., 2000; Smith et al., 2008), but in our assays
neither deletion of the cnf1 gene nor expression of recombinant
CNF1 affected the ability of UTI89 to stimulate paxillin degrada-
tion (Figure 2C).
The hly operon also encodes the acyltransferase HlyC, which
is responsible for acylating two conserved lysine residues within
maturing HlyA toxinmolecules. In the absence of acylationmedi-
ated by HlyC, HlyA is secreted and interacts with host cell
membranes, but fails to oligomerize to form functional pores
(Herlax et al., 2009; Stanley et al., 1998). Infection of BECs with
WAM582, a K-12 strain that carries the complete wild-type hly
operon, promoted rapid degradation of paxillin similar to hly-
positive UPEC isolates (Figure 2D). In contrast, paxillin remained
stable in BECs following infection with the isogenic mutant
WAM783, which encodes the hly operon minus hlyC. Of note,
both WAM783 and WAM582 express similar amounts of HlyA
as determined by western blot (data not shown). Complementa-
tion of WAM783 with a plasmid encoding HlyC made this strain
(WAM783/pHlyC) hemolytic and able to induce paxillin degrada-
tion (Figure 2D). Crude, bacteria-free preparations of acylated
HlyA recovered from WAM783/pHlyC culture supernatants also
triggered paxillin degradation, while nonacylated HlyA prepara-
tions isolated from WAM783 cultures had no effect on the
stability of paxillin (Figure 2E).ost & Microbe 11, 58–69, January 19, 2012 ª2012 Elsevier Inc. 59
Figure 2. HlyA Triggers Paxillin Degradation in BECs along with the Disruption of Host Actin and Microtubule Networks
(A) Western blots show levels of paxillin and actin in 5637 BECs following 4 hr infections with UPEC isolates, non-UPEC E. coli strains, or non-E. coli
uropathogenic bacteria. Uninfected (UI) control cells were treated with M9mediumwithout bacteria. Bacterial strains were scored as hemolytic (+) based on their
ability to lyse erythrocytes on blood agar plates.
(B–D) Western blots show paxillin and actin levels present in BECs at the indicated time points after infection with wild-type UTI89, UTI89DhlyA, UTI89DhlyA/
pSF4000, UTI89Dcnf1, UTI89Dcnf1/pHLK102, WAM783 (+hlyABD DhlyC), or WAM582 (+hlyCABD).
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ated HlyA into host membranes can trigger paxillin degradation,
but do not rule out possible involvement of additional bacterial
factors common to both K-12 and UPEC isolates. This process
did not require lytic concentrations of HlyA, as BECs intoxicated
with HlyA in these experiments remained for the most part intact
and viable as determined by trypan blue exclusion assays.
However, bacterial strains expressing wild-type HlyA did cause
substantial rounding and eventual lifting of the BECs (Figures
2F, S2A, and S2B), coincident with massive disruption of host
microtubule and actin networks (Figure 2G).
Effects of HlyA Membrane Insertion and Downstream
Signaling Events
In addition to acylation by HlyC, the lytic activity of HlyA is also
dependent upon extracellular Ca2+ (Bauer and Welch, 1996; Os-
tolaza and Gon˜i, 1995). This cation binds C-terminal GGXGXD
repeats within HlyA and promotes proper folding and insertion
of the toxin into the host cell plasma membrane where it likely
becomes concentrated and oligomerizes within cholesterol-
rich detergent resistant microdomains (Baka´s et al., 1998; Herlax
et al., 2009; Ludwig et al., 1988). In our assays, depletion of
cholesterol (using methyl b-cyclodextran, MbCD) or chelation
of extracellular Ca2+ (using EGTA) prevented the stable associa-
tion of HlyA with BECs (Figure S3G), completely inhibiting both
the cytotoxic effects of HlyA and paxillin degradation within
UTI89-infected BECs (Figures 2H, 2I, and S3H and data not
shown).
PFTs like HlyA can stimulate intracellular Ca2+ fluxes, the
release of cellular K+ ions, and activation of mitogen-activated
protein (MAP) kinases (Bhakdi et al., 1986; Koschinski et al.,
2006; Porta et al., 2011). However, neither intracellular Ca2+
fluxes nor K+ efflux affected the loss of paxillin within UTI89-in-
fected BECs, and inhibition of MAP kinase signaling caused at
best only a modest delay in paxillin degradation (Figures 2I and
S2C–S2F). In addition, two other PFTs (a-toxin from S. aureus
and aerolysin from Aeromonas hydrophila) with the ability to alter
cellular cation fluxes and MAP kinase signaling failed to trigger
the proteolysis of paxillin (Figure S2G). We also ruled out the
involvement of host purinergic P2X receptors and pannexin1
channels, whichwere recently proposed to amplify the hemolytic
effects of HlyA (Figure S3) (Skals et al., 2009). Interestingly, three
P2X antagonists—suramin, EvansBlue, andBrilliant BlueG—did
effectively block HlyA-induced paxillin degradation in our
assays, but appeared to do so by nonspecifically inhibiting the
stable association of HlyA with BECs, similarly to MbCD and
EGTA (Figure S3G). Thus, while our data refute the involvement
of P2X receptors and pannexin1 as necessary facilitators of
HlyA-induced paxillin degradation, they substantiate the idea
that loss of paxillin within infected BECs requires the stable
insertion of HlyA into target host membranes.(E)Western blots showpaxillin and actin levels in 5637 BECs following 0 to 4 hr incu
wild-type HlyA (HlyA783/pHlyC).
(F) Phase contrast microscopy of BECs infected with UTI89 or UTI89DhlyA for th
(G) Confocal images of BECs infected for 4 hr with UTI89 or UTI89DhlyA and the
(H and I) BECs were infected with UTI89 for the indicated times in the presence of M
or vehicle alone (DMSO, control). Paxillin and actin levels were assessed by wes
Cell HHlyA-Dependent Activation of Caspases andHost Serine
Proteases
HlyA is not known to have any inherent proteolytic activity, sug-
gesting that it may stimulate paxillin degradation by activation of
one or more host proteases. Using pharmacological inhibitors,
we tested the possible involvement of several of the better-
known proteolytic pathways in eukaryotic cells. Our results indi-
cated that the proteosome, calpains, and lysosomal proteases
like cathepsins are likely not critical for paxillin degradation in
response to HlyA (Figures S4A–S4C).
We also examined possible involvement of caspases, a family
of conserved aspartate-specific cysteine proteases (caspases,
CASP1–12) that have central roles in the initiation and execution
of apoptosis (Chowdhury et al., 2008). Using fluorochrome-
labeled inhibitor of caspases (FLICA) reagents (Bedner et al.,
2000), we found that wild-type UTI89, but not the isogenic hlyA
mutant, stimulates rapid activation of the executioner caspases
CASP3 and CASP7 in BECs (Figure 3A). The addition of suramin,
which interferes with the effects of HlyA on BECs (see Figure S3),
prevented caspase activation by UTI89 (Figure 3B). These data
indicate that HlyA expression by UPEC activates caspases
within BECs, in agreement with previous studies showing that
HlyA can promote apoptosis in a variety of host cell types
(Chen et al., 2006; Jonas et al., 1993; Mobley et al., 1990; Russo
et al., 2005). HlyA-induced caspase activation in our assays
correlated with the degradation of paxillin, suggesting a func-
tional link between these events. However, the treatment of
UTI89-infected BECs with the CASP3/7-specific inhibitor
Z-DEVD-FMK, the pan-caspase inhibitor Z-VAD-FMK, or the
CASP1/4 inhibitor Z-YVAD-FMK failed to prevent loss of paxillin
downstream of HlyA intoxication (Figure 3C). Thus, while HlyA
stimulates caspase activation within infected BECs, these prote-
ases are not integral to paxillin degradation in our experiments.
Caspases often act in concert with other proteolytic enzymes,
including serine proteases (Moffitt et al., 2007). These enzymes
make up more than one third of all known proteases and func-
tion in wide-ranging biological processes (Page and Di Cera,
2008). A role for serine proteases as mediators of paxillin degra-
dation in response to HlyA was assessed using the chymo-
trypsin-like serine protease inhibitor tosyl-L-phenylalanine-
chloromethyl ketone (TPCK) and the trypsin-like serine protease
inhibitor tosyl-L-lysine-chloromethyl ketone (TLCK). TPCK had
no notable effect on paxillin stability in UTI89-infected BECs
(data not shown), whereas TLCK completely inhibited HlyA-
induced paxillin proteolysis (Figure 3D). Of note, TLCK did not
interfere with the stable association of HlyA with BECs (Fig-
ure S3G), and also had no effect on either HlyA-induced round-
ing of target host cells (Figure S3H) or HlyA-dependent activa-
tion of caspases (Figure 3B). The latter observation, and the
inability of caspase inhibitors to block paxillin degradation in
our assays, indicates that serine proteases are activated inbationswith preparations of crude, bacteria-free nonacylated HlyA (HlyA783) or
e indicated times. Scale bar, 50 mm.
n stained to visualize microtubules or F-actin. Scale bar, 20 mm.
bCD (5mM), EGTA (4 mM), the intracellular Ca2+ chelator BAPTA-AM (10 mM),
tern blots. See also Figure S2 and Table S1.
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Figure 3. Activation of Caspases and TLCK-Sensitive Serine Proteases by HlyA
(A) Caspase-3/7 activation over time in 5637 BECs infected with UTI89 or UTI89DhlyA, as determined by fluorometry of FLICA-treated samples. Data are
expressed as the mean ± SEM of three independent experiments carried out in duplicate or triplicate. *p% 0.0001, as determined by Student’s t test.
(B) Effects of suramin (1 mM) and TLCK (100 mM) on caspase-3/7 activation in BECs infected for 4 hr with UTI89, as quantified by fluorometry of FLICA-treated
samples. Control UTI89-infected samples were treated with vehicle alone. Data are expressed as themean ± SEM of four independent experiments performed in
triplicate. *p% 0.0001, versus control values, as determined by Student’s t test.
(C) Western blots showing levels of paxillin and actin in BECs infected with UTI89 for the indicated times in the presence of 100 mM of the CASP3/7-specific
inhibitor Z-DEVD-FMK, the pan-caspase inhibitor Z-VAD-FMK, the CASP1/4 inhibitor Z-YVAD-FMK, or the negative control Z-FA-FMK.
(D) Paxillin and actin levels in BECs infected with UTI89 for the indicated times in the presence or absence of TLCK (100 mM), as determined by western blots.
(E) Phase contrast (left) and corresponding fluorescent images (right) of BECs infected with UTI89 or UTI89DhlyA for 4 hr in the presence of the fluorescent probe
FSLCK (5 mM). Scale bar, 20 mm.
(F) Fluorometric quantification of the levels of FSLCK-labeled, active serine proteases over time in BECs infected with UTI89 or UTI89DhlyA. Data are expressed
as the mean ± SEM of three independent experiments carried out in triplicate. *p% 0.0001, as determined by Student’s t test.
(G) Immunoblots probed using anti-FITC antibody to detect FSLCK-tagged proteins recovered from uninfected BECs, BECs infected with UTI89DhlyA, or BECs
infected with UTI89 ± 1 mM suramin.
(H) Levels of activated FSLCK-tagged serine proteases present in the bladder mucosa of mice 5 hr after infection with UTI89 or UTI89DhlyA were quantified by
fluorometry. Data are expressed as the mean ± SEM from at least five mice. *p = 0.0017, as determined by Student’s t test.
(I) Activated serine proteases present in the bladder mucosa of uninfected mice or mice infected with UTI89 or UTI89DhlyA for 5 hr were detected, following
treatment with FSLCK, by western blots probed with anti-FITC antibody. Further analysis by mass spectroscopy identified the 23 kDa band (arrow) as meso-
trypsin. See also Figure S3.
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of, caspases.
Carboxyfluorescein-spacer-leucine chloromethyl ketone
(FSLCK) covalently binds and fluorescently tags activated serine
proteases (Grabarek and Darzynkiewicz, 2002). Using FSLCK as
a probe, we observed by fluorescent microscopy high levels of
activated serine proteases in UTI89-infected BECs, versus rela-
tively low levels in host cells infected with the isogenic hlyA
mutant (Figure 3E). Fluorometric quantitation of BECs probed
with FSLCK confirmed that wild-type UTI89 caused significant
activation of serine proteases within 2 hr of infection, while the
hlyA mutant elicited almost no changes above background
(Figure 3F). By western blot analysis, using antibody specific
for the carboxyfluorescein fluorochrome within FSLCK, multiple62 Cell Host & Microbe 11, 58–69, January 19, 2012 ª2012 Elsevier IFSLCK-tagged protein bands were detected in lysates from
BECs following a 3 hr infection with wild-type UTI89 (Figure 3G).
The number and intensities of the bands were markedly reduced
in lysates from BECs infected with the hlyA mutant, and nearly
absent in lysates from uninfected BECs or BECs that were in-
fected with UTI89 in the presence of suramin. In total, these
results indicate that HlyA can trigger the robust activation of
TLCK-sensitive serine proteases within BECs, one or more of
which mediate paxillin degradation.
Mesotrypsin Promotes Paxillin Degradation
Downstream of HlyA
To examine the ability of HlyA to influence activation of serine
proteases in vivo within the bladder, we utilized FSLCK innc.
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ometry, significantly higher levels of activated serine proteases
were detected within the bladder mucosa of mice following
infectionwithwild-typeUTI89 versus the hlyAmutant (Figure 3H).
Western blots of bladder mucosa lysates from both infected and
uninfected mice revealed only two FSLCK-tagged protein bands
with apparent molecular weights of about 23 and 70 kDa (Fig-
ure 3I). Similarly sized FSLCK-tagged protein bands were also
detected, among many others, in UTI89-infected BECs in our
cell culture-based assays (arrowheads, Figure 3G). FSLCK
labeling of the 23 kDa protein band was consistently more
intense following infection of either cultured BECs or mouse
bladders with wild-type UTI89 relative to UTI89DhlyA-infected
samples and uninfected controls.
Using an immunoprecipitation approach coupled with mass
spectroscopy, we identified the 23 kDa FSLCK-tagged protein
in lysates fromUTI89-infectedmouse bladders as a TLCK-sensi-
tive host serine protease known as mesotrypsin. This enzyme is
generated via processing of three zymogens, known as trypsin-
ogens 3, 4, and 5, that are produced as splice variants of the
genePRSS3 (Nakanishi et al., 2010). These trypsinogen isoforms
differ only in their N-terminal region, which is cleaved at
conserved DDDDK-I sequences by the type II transmembrane
serine protease enteropeptidase to produce active mesotrypsin
(Light and Janska, 1989). The mesotrypsin enzyme is highly
similar to trypsins 1 and 2, major pancreatic digestive proteases
derived from the zymogenic precursors trypsinogens 1 and 2,
respectively (Nakanishi et al., 2010). However, relative to trypsins
1 and 2, mesotrypsin has distinct substrate specificity and
a higher level of resistance to many natural, endogenous
protease inhibitors (Nakanishi et al., 2010; Sahin-To´th, 2005).
Among trypsinogens 1 through 5, only trypsinogen 4 tran-
scripts were detected by RT-PCR in the human BECs used in
our cell culture-based assays (Figure 4A). Transcription of the
activating enzyme enteropeptidase in these host cells was also
observed. Using siRNA to silence expression of trypsinogen 4
(PRSS3, Figure 4B), we were able to significantly delay the
degradation of paxillin in UTI89-infected BECs (Figure 4C).
These data indicate that the active form of trypsinogen 4, meso-
trypsin, is at least partially responsible for loss of paxillin in
HlyA-intoxicated BECs. Interestingly, we found that trypsinogen
4 undergoes radical redistribution in response to HlyA, as in-
ferred from using immunofluorescence microscopy with anti-
body directed against the enteropeptidase cleavage site DDDDK
(anti-ECS antibody, Figure 4D). Use of the anti-ECS antibody
serves as a reasonable surrogate for direct immunodetection
of trypsinogen 4, as none of the other known trypsinogens
appear to be expressed by the BECs used in our assays (see
Figure 4A) (Nakanishi et al., 2010). In the presence of HlyA, tryp-
sinogen 4moves from a diffuse, primarily cytosolic localization to
amore reticulated and punctate distribution at the cell periphery,
along microtubules, and within and around nuclei (Figures 4D
and S4D). This process is initiated within 1 hr of infection with
wild-type UTI89, preceding the loss of paxillin.
TLCK-Sensitive, HlyA-Dependent Proteolysis
of Multiple Host Proteins
Induced activation of mesotrypsin and, perhaps, other TLCK-
sensitive proteases by HlyA likely has effects extending beyondCell Hpaxillin degradation. To examine this possibility, lysates from
BECs that were infected with wild-type UTI89 in the presence
or absence of TLCK, or with UTI89DhlyA, were assayed by
western blot analyses using antibodies specific for a panel
of 24 host proteins. Nearly half of these were degraded in
a TLCK-sensitive fashion within 4 hr of infection with wild-type
UTI89, but not the hlyA mutant (Figures 5A and 5B). Although
these assays were too restricted to discern any definitive pattern
in the types of host proteins that are degraded in response to
HlyA intoxication, they do demonstrate the ability of HlyA to
stimulate the loss of many proteins with key roles in mediating
host cell adherence and signal transduction. These include the
paxillin homolog Hic-5, the docking proteins HEF-1 and p130-
CAS, and the adherens junction component and signaling factor
b-catenin.
In addition to its role as a mediator of cell adhesion, b-catenin
also functions in developmental and oncogenic cascades within
the Wnt signaling pathway and as a negative regulator of the
proinflammatory transcription factor NFkB (Deng et al., 2002).
Interestingly, the TLCK-sensitive degradation of b-catenin in
UTI89-infected BECs occurs in step with loss of the prototypical
inhibitor of NFkB signaling, IkBa (Figure 5B). Usually, IkBa is
ubiquitinated and subsequently degraded by the proteasome
in response to proinflammatory signals (Rahman andMcFadden,
2011). However, the rapid loss of IkBa in our assays required
HlyA and one or more TLCK-sensitive protease, indicating a
proteasome-independent mechanism for IkBa degradation in
response to HlyA intoxication. Coincident with loss of IkBa and
b-catenin, we also observed HlyA-dependent and TLCK-sensi-
tive degradation of the NFkB subunit RelA (also known as p65)
(Figure 5B). This correlated with significantly reduced expression
of the NFkB-regulated cytokine IL-6 by HlyA-intoxicated BECs in
response to added lipopolysaccharide (LPS, Figure 5C). In total,
these data indicate that HlyA can indirectly disrupt various
aspects of host cell signaling, including key components of the
NFkB pathway, via effects on serine proteases.
HlyA-Induced Proteolysis of Macrophage Proteins
We next asked if the effects of HlyA on the stability of select host
proteins could be observed in host cell types other than BECs.
Using both the RAW264.7 macrophage cell line and mouse peri-
toneal macrophages, we found that wild-type UTI89, but not the
hlyAmutant, triggered the degradation of paxillin as well as IkBa
andRelA (Figures 6A–6C). Labeling of activated serine proteases
with the FSLCK reagent was also more intense in macrophages
infected with wild-type UTI89 versus UTI89DhlyA (Figure 6D).
Thus, the capacity of HlyA to activate serine proteases and
promote the loss of select host proteins is not limited to BECs.
DISCUSSION
In recent years, sublytic concentrations of several bacterial PFTs
have been shown to modulate important aspects of host cell
physiology, including MAP kinase and Akt signaling, inflamma-
some activation, plasma membrane repair systems, histone
methylation, the unfolded protein response, and mitochondrial
function (Aroian and van der Goot, 2007; Bischof et al., 2008;
Gonzalez et al., 2011; Hamon et al., 2007; Kao et al., 2011; Los
et al., 2011; Porta et al., 2011; Stavru et al., 2011; Wiles et al.,ost & Microbe 11, 58–69, January 19, 2012 ª2012 Elsevier Inc. 63
Figure 4. HlyA-Induced Paxillin Degradation Is Facilitated by Mesotrypsin
(A) 5637 BECs express enteropeptidase and trypsinogen 4, but not other trypsinogens, as determined by RT-PCR.
(B) Semiquantitative RT-PCR shows levels of PRSS3 (encoding trypsinogen 4) and GAPDH transcripts in BECs 72 hr after transfection with either control
nonspecific siRNA or PRSS3-specific siRNA.
(C) Western blots show levels of paxillin and actin present in lysates recovered from BECs treated with control, nonspecific siRNA or PRSS3-specific siRNA and
infected with UTI89 for the indicated times.
(D) Confocal micrographs of uninfected BECs or BECs that were infected with UTI89 or UTI89DhlyA for the indicated times and then stained to visualize
trypsinogens (using ECS antibody, green), LAMP1 (red), and nuclei (blue). The boxed area in each micrograph is enlarged and placed directly below the
corresponding image to show details. Scale bars, 20 mm (first and third rows) and 5 mm (second and fourth rows). See also Figure S4.
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able to toxin-induced fluctuations in intracellular K+ and/or Ca2+
levels. In our efforts to identify UPEC-associated factors that
influence BEC detachment, using paxillin degradation as a
readout, we found that the PFT HlyA can trigger activation of
TLCK-sensitive serine proteases independent of K+ and Ca2+
fluxes. This process required stable interaction between HlyA
and the host cells, likely involving oligomerization and integration
of the acylated, Ca2+-bound toxin into cholesterol-rich microdo-
mains within the host plasma membrane. Two other bacterial
PFTs, a-toxin and aerolysin, had no effect on the stability of
paxillin, even though they, like HlyA, can stimulate K+ and Ca2+
fluxes (Krause et al., 1998; Seeger et al., 1984). These results
indicate that the capacity of HlyA to promote loss of paxillin is
not shared by all PFTs.64 Cell Host & Microbe 11, 58–69, January 19, 2012 ª2012 Elsevier IDegradation of paxillin in response to HlyA intoxication is due
at least in part to activation of mesotrypsin. This protease has
recently been shown to regulate the differentiation and desqua-
mation of keratinocytes within the outermost layer of the skin
epidermis (Nakanishi et al., 2010). We suggest that mesotrypsin
might serve a similar function within the bladder mucosa. Unlike
its close relatives, trypsins 1 and 2, mesotypsin is more widely
expressed and is resistant to many naturally occurring trypsin
inhibitors (Nakanishi et al., 2010; Sahin-To´th, 2005). In some
cases, mesotrypsin can also degrade endogenous protease
inhibitors, meaning it has the capacity to regulate the function-
ality of other proteolytic enzymes (Sahin-To´th, 2005). In our
assays, silencing the expression of PRSS3 significantly delayed
HlyA-induced degradation of paxillin in BECs. Eventual loss
of paxillin in these assays likely results from our inability tonc.
Figure 5. Widespread Effects of HlyA on Host Protein Stability and NFkB Signaling
(A–B) Levels of the host proteins indicated were assessed by western blot using lysates from 5637 BECs infected for 0 to 4 hr with UTI89DhlyA or wild-type
UTI89 ± TLCK (100 mM).
(C) 5637 BECs were infected with UTI89DhlyA or wild-type UTI89 in the presence of LPS (5 mg/ml) or incubated with LPS alone, and 4 hr later IL-6 levels in the cell
culture supernatants were measured by ELISA. Data are expressed as the mean ± SEM of results from at least three independent experiments performed in
triplicate; p values were determined by Student’s t test.
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ment of other host, or perhaps even bacterial, trypsin-like serine
proteases. The proteolysis of paxillin and other host proteins in
response to HlyA intoxication correlated with the redistribution
of mesotrypsin precursors from the cytosol to punctate struc-
tures situated primarily along microtubules, both at the cell
periphery and around and within host nuclei. The means by
which HlyA triggers these positional changes and actually
signals mesotrypsin activation within BECs require further
investigation.
UPEC strains that express HlyA cause more extensive tissue
damage within the urinary tract, correlating with more severe
clinical outcomes (Johnson, 1991; Marrs et al., 2005; Smith
et al., 2008). In both murine and tissue culture model systems,
hlyA-positive isolates stimulate more rapid and extensive shed-
ding of BECs than isogenic hlyA-negative mutants (see Figures
S2A and S2B) (Smith et al., 2006; Smith et al., 2008). HlyA is
also an important virulence factor associated with other closely
related E. coli strains that can cause pneumonia, peritonitis,
and septicemia (May et al., 2000; O’Hanley et al., 1991; Russo
et al., 2005; Welch et al., 1981; Wiles et al., 2009). In the gut,
HlyA mediates the formation of focal leaks within colonic
epithelial cells and can thereby promote the paracellular trans-Cell Hlocation of bacteria (Troeger et al., 2007). HlyA can also atten-
uate the viability, chemotaxis, and effector functions of host
phagocytes like neutrophils and macrophages (Cavalieri and
Snyder, 1982a, 1982b; Gadeberg et al., 1989; Russo et al.,
2005).
Results presented here suggest molecular processes by
which sublytic levels of HlyA can modulate the functionality
and viability of diverse host cell types. The ability of HlyA to elicit
degradation of paxillin as well as other cytoskeletal regulatory
and structural components may not only promote bladder cell
exfoliation, but can also act to cripple phagocytes. Coordinated
activation of both serine proteases and caspases in response to
HlyA intoxication represents an additional mechanism by which
this PFT can compromise host cell viability. The capacity of HlyA
to stimulate degradation of b-catenin, IkBa, and the NFkB
subunit RelA may enable UPEC and related strains to promote
host cell death while also attenuating host inflammatory
responses. The TLCK-sensitive nature of these degradative
processes suggests a role for HlyA-activated serine proteases
like mesotrypsin in the regulation of NFkB signaling. These
results add to the growing list of mechanisms used by microbial
pathogens to disturb NFkB-dependent proinflammatory path-
ways (Rahman and McFadden, 2011).ost & Microbe 11, 58–69, January 19, 2012 ª2012 Elsevier Inc. 65
Figure 6. HlyA Triggers the Activation of Serine
Proteases and Degradation of Host Proteins within
Macrophages
(A–B) Western blots showing levels of paxillin and actin in
either RAW264.7 or mouse peritoneal macrophages
following infection with either UTI89 or UTI89DhlyA for the
indicated times.
(C)Western blots showing levels of IkBa, RelA, and actin in
RAW264.7 cells following infection with UTI89 or
UTI89DhlyA for the times indicated.
(D) Phase contrast (left) and corresponding fluorescent
images (right) of peritoneal macrophages infected with
UTI89 or UTI89DhlyA for 3 hr in presence FSLCK (5 mM) to
label activated serine proteases. Scale bar, 50 mm.
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kine expression complement previous findings showing that
HlyA can inactivate Akt, another key regulator of host cell survival
and inflammation (Wiles et al., 2008). Together, these data
explain in large part the capacity of some UPEC isolates to
suppress host inflammatory responses, as reported by others
(Billips et al., 2007; Hilbert et al., 2008; Hunstad et al., 2005;
Loughman and Hunstad, 2011). Interestingly, in some of these
earlier studies mutations that alter the ability of UPEC to dampen
host cytokine expression levels were mapped to genes that
affect the bacterial cell envelope and, potentially, the secretion
of toxins like HlyA. In conclusion, our data reveal an unexpected
process by which UPEC and related pathogens can manipulate
host survival and inflammatory pathways via HlyA-dependent
activation of host proteolytic cascades.EXPERIMENTAL PROCEDURES
Host Cells and Bacterial Strains
Human bladder epithelial cells, designated 5637 cells (ATCC HTB-9), were ob-
tained from the American Type Culture Collection and maintained in RPMI
1640 supplemented with heat-inactivated 10% fetal bovine serum (Hyclone,66 Cell Host & Microbe 11, 58–69, January 19, 2012 ª2012 Elsevier Inc.Logan, UT) at 37C in the presence of 5% CO2. Peritoneal
and RAW264.7 macrophages were used as described in
Supplemental Experimental Procedures. Bacterial strains
employed in this study are listed in Table S1. All E. coli
strains were grown static in M9 minimal medium at 37C
for 48 hr prior to use (Wiles et al., 2008). S. flexneri
(ATCC 12022), S. enterica ser. Typhimurium (SL1344),
S. saprophyticus, S. aureus, E. faecium, and
K. pneumoniae were grown with shaking in Luria-Bertani
(LB) broth (Difco) overnight. Bacteria were diluted in M9
medium (or LB broth for the non-E. coli isolates) to
OD600 0.5 prior to use. Antibodies, purified toxins, and
other reagents used are noted in Supplemental
Information.
Infection Assays, Western Blots, and Gene
Expression Analysis
Confluent BEC monolayers grown in 6-well plates were
serum starved overnight in 1 ml of RPMI prior to infection
or drug treatments. When appropriate, BECs were treated
with the indicated compounds or vehicle alone for 1 hr
prior to infection with UPEC. Host cells were infected
with 100 ml of diluted bacterial cultures, corresponding to
a multiplicity of infection of about 25. Fresh drugs, vehicle,
or other compounds were added at this time and main-
tained for the duration of each experiment as needed. Sur-amin was also added fresh again at 2 hr after infection to maintain its effective-
ness. An aliquot of M9 medium was added as a control to the uninfected
samples. Plates were centrifuged at 6003 g for 5min to facilitate and synchro-
nize bacterial contact with the host cells. At the specified times, BECs were
washed with PBS2+ (PBS supplemented Ca2+ and Mg2+) prior to lysis in
RIPA buffer supplemented with 13 complete protease inhibitors (Roche
Applied Science) and 1 mM phenylmethanesulfonylfluoride (Sigma-Aldrich).
Equivalent protein amounts (typically 50 mg of each sample, as determined
by BCA assays; Pierce) were resolved by SDS-PAGE, transferred to Immobi-
lon PVDF-FLmembrane (Millipore), and processed for western blot analysis as
previously described (Eto et al., 2007; Wiles et al., 2008). Gene cloning,
silencing, semiquantitative RT-PCR, and the isolation of crude HlyA prepara-
tions were carried out as detailed in Supplemental Experimental Procedures.
Detection and Quantification of Activated Caspases and Serine
Proteases
Confluent, serum-starved BEC monolayers in 24-well plates were treated with
the FLICA reagents FAM-DEVD-FMK (13), SR-DEVD-FMK (13), or FSLCK
(5 mM, ImmunoChemistry Technologies; Bloomington, MN) and then infected
with UTI89 or UTI89ΔhlyA ± suramin (1 mM) or TLCK (100 mM) as indicated. At
the specified times, BECs were washed 33with PBS2+ and lysed in TTD buffer
containing 0.25% Triton X-100, 10 mM Tris (pH 7.5), and 1 mM dithiothreitol.
Fluorescence measurements were obtained using a LS-5 Fluorescence spec-
trophotometer (Perkin-Elmer; Waltham, MA), and readings were normalized to
the total protein content in each sample, as determined by BCA assays.
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resolved by SDS-PAGE and probed by western blot analysis using anti-FITC
and anti-actin antibodies.
To assay activation of serine proteases in vivo within the bladder mucosa,
adult female CBA/J mice (Jackson Laboratories; Bar Harbor, ME) were inocu-
lated via transurethral catheterization with108 cfu of UTI89 or UTI89ΔhlyA as
described (Mulvey et al., 1998). Mice were sacrificed at 5 hr postinoculation
and bladders were aseptically removed, bisected, splayed, and pinned
down lumenal side up in mammalian Ringer solution (pH 7.4) containing
5 mM FSLCK. After a 20 min incubation at 37C, the splayed bladders were
washed five times with Ringer solution, and the mucosal layer of each bladder
was gently peeled off and lysed in TTD lysis buffer. FSLCK-tagged serine
proteases in each sample were quantified by fluorometry or visualized by
western blot analysis as described above.
To identify the 23 kDa active serine protease present within the bladders of
UTI89-infected mice, mucosal layers isolated from four infected, FSLCK-
treated bladders were pooled and lysed in RIPA buffer. FSLCK-tagged
proteins were then immunoprecipitated using rabbit anti-FITC antibody immo-
bilized on Protein A Sepharose 4B beads, resolved by SDS-PAGE, and stained
using GelCode Blue (Thermo Fisher Scientific). The 23 kDa band was then
excised, subjected to in-gel trypsin digestion and identified using liquid chro-
matography/mass spectrometry at the University of Utah core facility.
All mouse experiments were performed with approval from the local Institu-
tional Animal Care and Use Committee.
Microscopy
Phase contrast and fluorescencemicroscopic images of live BECs andmacro-
phages were acquired using an Olympus CK40 microscope equipped with
103 (Olympus A10PL NA 0.25) and 403 (Olympus CDPlan40FPL NA 0.55)
objectives and a Canon PowerShot A640 camera. For confocal microscopy,
BECs grown on 12 mm-diameter glass coverslips were fixed, stained, and
imaged using an Olympus FV1000 microscope as previously described
(Dhakal and Mulvey, 2009).
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, one table, Supplemental
Experimental Procedures, and Supplemental References and can be found
with this article online at doi:10.1016/j.chom.2011.12.003.
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